Last update:

Medications news

Medications

Single-dose oral treatment for gonorrhea effectively combats drug-resistant infections, clinical trial finds

A single-dose oral medication called zoliflodacin shows promise as a new treatment for antibiotic-resistant gonorrhea, according to a Phase III trial published in The Lancet.

Medications

ADHD prescriptions on the rise in Ontario, study finds

Annual prescriptions for drugs to treat attention-deficit/hyperactivity disorder (ADHD) increased 157% in Ontario from 2015 to 2023, according to a new study from researchers at ICES, North York General, and The Hospital ...

Medications

Examining hidden risks of cannabis use among older adults

Cannabis use is rising among older adults, fueled by expanded legalization and people increasingly turning to cannabinoid-containing products to manage pain, sleep problems and other chronic issues.

Medications

EU to reward antibiotic innovation with new pharma rules

Drugmakers that develop new antibiotics are set to benefit from longer market protection in Europe after the EU agreed Thursday to a wide-ranging reform of pharmaceutical rules seeking to boost innovation and tackle antimicrobial ...

Medications

Opioids: Clarifying the concept of safe supply to save lives

In Canada, thousands of people use contaminated street opioids. To reduce overdoses, the country has been experimenting for the past 10 years with the distribution of pharmaceutical opioids as an alternative to illicit drugs. ...

Medications

Online tool detects drug exposure directly from patient samples

Doctors and researchers try to understand what medications a person has taken by asking patients directly or by looking at medical records. But this information is often incomplete. People may forget what they took, use over‑the‑counter ...

Medications

FDA approves Itvisma for spinal muscular atrophy

The U.S. Food and Drug Administration has approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy (SMA) in patients 2 years and older with confirmed mutation in the survival motor neuron ...

Medications

Poorer countries granted access to HIV prevention drug

Lower-income countries will gain access to a "game-changing" HIV prevention drug with a new deal signed between US pharmaceutical giant Gilead and the Global Fund, the health financing group said Wednesday.

Medications

First infant malaria treatment receives approval: Novartis

The first malaria treatment for newborns and young infants has received approval from Swiss health regulators, with eight African countries poised to roll the drug out rapidly, pharmaceutical giant Novartis said Tuesday.

Medications

NRTI use linked to risk for primary open-angle glaucoma

Use of nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs) is associated with an increased risk for primary open-angle glaucoma (POAG), according to a study published online June 20 in Ophthalmology.